Clinical Trial Management Services Market (By Services; By Industry; By Indication: Immunology, Hematology, Oncology, Dermatology, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global clinical trial management services market was surpassed at USD 1.81 billion in 2021 and is expected to hit around USD 5.36 billion by 2030, growing at a CAGR of 12.82% from 2022 to 2030.

Clinical Trial Management Services Market Size 2021 to 2030

Report Summary

The global clinical trial management services market is anticipated to reflect considerable growth across the forecast period. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few of the factors supporting the growth of the clinical trial management services market.

The COVID-19 pandemic had a significant impact on the clinical trial management services market. It also created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

The oncology segment is anticipated to hold the highest market share in the clinical trial management services market. High shares of the segment are majorly due to increasing cases of cancer across the globe. As per the American Cancer Society, in 2021, there is an estimated 1.9 million new cancer cases diagnosed in the U.S.

The clinical trial management services market in the Asia Pacific is expected to witness the most lucrative growth in the forecast period. High growth is anticipated owing to factors such as the cheap labor cost, presence of a diversity of patient pool, less cost associated with clinical trial activities compared to the western economies, awareness about clinical trial services, and the presence of major CROs in the region. For instance, 75% of the players in the region operate globally, whereas 25% are regional players.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 1.81 billion
Revenue Forecast by 2030 USD 5.36 billion 
Growth rate from 2022 to 2030 CAGR of 12.82%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Services, Industry, Indication, Region
Companies Covered

LabCorp, IQVIA, Syneous Health, Atlantic Research Group, ICON Plc, and a few others

 

A few of the market players operating in the clinical trial management services market are LabCorp, IQVIA, Syneous Health, Atlantic Research Group, ICON Plc, and a few others. These companies are adopting various inorganic growth strategies such as mergers, collaborations, etc. For instance, in April 2021, Atlantic Research Group collaborated with Bio Products Laboratory (BPL) to provide clinical trial management services to BPL’s global new product development programs. Such initiatives support the growth of the company across the clinical trial management services market.

Market Segmentation

  • By Services
    • Clinical Trial Monitoring
    • Regulatory Submissions
    • Clinical Trial Data Management
    • Medical Writing
    • Site management & monitoring
    • Others
  • By Industry
    • Pharmaceuticals
    • Biopharmaceuticals
    • Medical Devices
  • By Indication
    • Immunology
    • Hematology
    • Oncology
    • Dermatology
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Clinical Trial Management Services Market 

5.1. COVID-19 Landscape: Clinical Trial Management Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Clinical Trial Management Services Market, By Services

8.1. Clinical Trial Management Services Market, by Services, 2022-2030

8.1.1 Clinical Trial Monitoring

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Regulatory Submissions

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Clinical Trial Data Management

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Medical Writing

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Site management & monitoring

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Clinical Trial Management Services Market, By Industry

9.1. Clinical Trial Management Services Market, by Industry, 2022-2030

9.1.1. Pharmaceuticals

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Biopharmaceuticals

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Medical Devices

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Clinical Trial Management Services Market, By Indication 

10.1. Clinical Trial Management Services Market, by Indication, 2022-2030

10.1.1. Immunology

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Hematology

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Oncology

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Dermatology

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Clinical Trial Management Services Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Services (2017-2030)

11.1.2. Market Revenue and Forecast, by Industry (2017-2030)

11.1.3. Market Revenue and Forecast, by Indication (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Industry (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Indication (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Industry (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Indication (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.2. Market Revenue and Forecast, by Industry (2017-2030)

11.2.3. Market Revenue and Forecast, by Indication (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Industry (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Indication (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Industry (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Indication (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Industry (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Indication (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Industry (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Indication (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.2. Market Revenue and Forecast, by Industry (2017-2030)

11.3.3. Market Revenue and Forecast, by Indication (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Industry (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Indication (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Industry (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Indication (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Industry (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Indication (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Industry (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Indication (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.2. Market Revenue and Forecast, by Industry (2017-2030)

11.4.3. Market Revenue and Forecast, by Indication (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Industry (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Indication (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Industry (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Indication (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Industry (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Indication (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Industry (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Indication (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.5.2. Market Revenue and Forecast, by Industry (2017-2030)

11.5.3. Market Revenue and Forecast, by Indication (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Industry (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Indication (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Industry (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Indication (2017-2030)

Chapter 12. Company Profiles

12.1. LabCorp

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. IQVIA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Syneous Health

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Atlantic Research Group

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. ICON Plc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. others

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers